However, to our knowledge, the expression and role of CCR4 in prostate cancer have not been reported so far, and little is known about the relationship between TAMs and the CCL2–CCR2 and CCL17/CCL22–CCR4 axes with regard to tumor migration and invasion in prostate cancer. This evidence concerns the gene CCL2 and prostate cancer.